The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126061703 12606170 3 F 20160919 20160729 20160922 PER US-PFIZER INC-2016365376 PFIZER 0.00 M Y 0.00000 20160922 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126061703 12606170 1 PS LYRICA PREGABALIN 1 150 MG, 2X/DAY U 21446 150 MG BID
126061703 12606170 2 SS LYRICA PREGABALIN 1 150 MG, 1X/DAY U 21446 150 MG QD
126061703 12606170 3 SS GABAPENTIN. GABAPENTIN 1 UNK, 1X/DAY (IN THE EVENING) U 20235 QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126061703 12606170 1 Diabetic neuropathy

Outcome of event

Event ID CASEID OUTC COD
126061703 12606170 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126061703 12606170 Anxiety
126061703 12606170 Insomnia
126061703 12606170 Suicidal ideation

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found